Navigation Links
Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Date:3/1/2011

on
  • SG&A: $23 to $25 million

  • Planned capital investments for the commercial business, including manufacturing debottlenecking, are expected to be between $4 and $6 million.  In addition, the Company expects to spend up to $10 million to build out a new San Diego, CA facility over the next two years and is exploring opportunities for spreading the capital expenditure over a longer period of time.

    About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

    Forward-Looking StatementsStatements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, risks associated with Verenium's technologies, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operate
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Verenium Announces 2010 Business Update and Outlook for 2011
    2. Verenium Announces Changes in Senior Management
    3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    4. Spherix Reports Second Quarter Earnings
    5. Tapestry Reports Second Quarter 2007 Results
    6. Callisto Reports on Second-Quarter 2007 Milestones
    7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    11. Biopure Reports on Meeting with the FDA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
    (Date:8/29/2014)... Aug. 29, 2014 /PRNewswire/ –  Royal ... AEX: PHIA) today announced its ... of Cardiology (ESC) Congress 2014 , where ... of its cardiology solutions serving clinicians and patients ... and diagnosis, to treatment, recovery ...
    (Date:8/28/2014)... YORK , Aug. 28, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Forecast 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... delivery – discover technological and commercial prospects ... needle-free delivery market? Visiongain,s brand new report ...
    Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
    ... LOUIS, Oct. 27, 2011 Sigma-Aldrich Corporation (NASDAQ: ... and services business unit, SAFC® ( www.safcglobal.com ), is ... Chinese Hamster Ovary (CHO) cell line. Designed for use ... cell line is the first commercially available glutamine synthetase ...
    ... is announcing expansion of its client oncology programs, ... and clinical trial execution, of pharmaceutical and biological ... gene therapies, and novel small molecules.  Senior associates ... development provide clients with hands-on guidance throughout the ...
    Cached Medicine Technology:SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients 2
    (Date:8/29/2014)... HealthDay Reporter THURSDAY, Aug. ... American babies are getting the vaccines they need to ... Thursday. More than 90 percent of children are ... (MMR); polio; hepatitis B and chickenpox (varicella), according to ... "Nationally, vaccination among children 19 to 35 months of ...
    (Date:8/29/2014)... Edvance360, a leading provider of eLearning solutions, ... as well as 2011 winner and six-time-finalist for the ... announced that Brooke Education Services, Northwest Academy, Typewell, Dialysis ... Bureau of Canada (IAB Canada), StarSVCS, and HMG Plus, ... to welcome each new client to the growing Edvance360 ...
    (Date:8/29/2014)... Washington University School of Medicine have identified one way ... important insight that could lead to new therapies, in ... Cell Host & Microbe . , In work performed ... Source, the researchers developed a detailed map of how ... protein that takes signaling molecules in and out of ...
    (Date:8/29/2014)... Columbus, Georgia (PRWEB) August 29, 2014 The ... including Shop & Dine for a Cause, Pink Pooch Contest, ... Day, and "Forget Me Knots" Pink Bow Campaign – all ... a new addition and twist this year…. Paint Columbus Pink ... 9:00 am at Cascade Hills, 727 54th Street, Columbus, Georgia ...
    (Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
    Breaking Medicine News(10 mins):Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Edvance360 Continues to Experience Growth in Corporate, K-12, Health, and Non-Profit Sectors 2Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2
    ... Scientists are discovering promising approaches to treating pain, one ... to research released today at Neuroscience 2011, the annual ... largest source of emerging news about brain science and ... reduce arthritis-related pain, and that a new opioid-like drug ...
    ... of Wisconsin have found a possible link between norovirus, ... food allergies. The findings are published in The ... M.D., associate professor of pediatrics, medicine, microbiology and molecular ... practicing at Children,s Hospital of Wisconsin, is the corresponding ...
    ... barren vacuum. The area seethes with electric and magnetic fields ... creating electric currents, and producing the aurora. Many of these ... million miles away on the surface of the sun. But ... source: Earth,s atmosphere. These are the particles being watched ...
    ... By Denise Mann HealthDay Reporter , MONDAY, ... a single injection of a man-made protein might lower ... abdomen, AMG145 reduced low-density lipoprotein (LDL) cholesterol ... turned off a newly identified cholesterol regulator, PCSK9, which ...
    ... multiforme in the Dock Glioblastoma multiforme (GBM) ... with GBM have a poor prognosis because it is a ... current therapies. A team of researchers led by Bo ... Institute, Pittsburgh has now identified a molecular pathway that ...
    ... fifth "Art of Science" competition whose theme is ... an online gallery: http://www.princeton.edu/artofscience/gallery2011/ "In ... a polarizing meaning," said Art of Science co-organizer Andrew ... the Princeton Plasma Physics Laboratory (PPPL) and a lecturer ...
    Cached Medicine News:Health News:Studies explore new approaches to treating pain 2Health News:New FASTSAT discoveries paint detailed view of region near Earth 2Health News:Shot Might One Day Help Lower Cholesterol 2Health News:Shot Might One Day Help Lower Cholesterol 3Health News:JCI online early table of contents: Nov. 14, 2011 2Health News:JCI online early table of contents: Nov. 14, 2011 3Health News:JCI online early table of contents: Nov. 14, 2011 4Health News:JCI online early table of contents: Nov. 14, 2011 5Health News:JCI online early table of contents: Nov. 14, 2011 6Health News:'Intelligent design' theme of Art of Science exhibit 2Health News:'Intelligent design' theme of Art of Science exhibit 3
    ... Camera from ImagingPlanet Research Microscopy ... delivers increased image resolution and precise ... Document, Archive and Publish with ... microscope camera designed for microscope or ...
    The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
    The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
    The DEI 750 MD from Optronics is a surgical 3 CCD color microscope camera with a 10 meter head cable. Easily mounts on your microscopes C-mount adapter and is the best choice for your surgical imagin...
    Medicine Products: